Associate VP, South & SE Asia
Director, Middle east & Africa
Director, South India, Bangladesh, Malaysia, Singapore, Indonesia
Director, North India, Thailand, Vietnam, Philippines
Associate Director, Africa , Turkey, Jordan
The upcoming edition of CPHI Worldwide will be held at the Messe Frankfurt from November 1st to 3rd. More than 2500 international exhibitors from 170+ countries and around 45,000 professionals, including a significant number of suppliers and decision-makers, are anticipated to participate.
CPhI Worldwide 2022 will offer a unique platform where market leaders can communicate and exchange knowledge with their target audiences and important industry personalities. In addition, there will be opportunities to explore a host of product categories and advanced solutions with state-of-the-art technologies.
We specialise in manufacturing and supplying a wide range of APIs for generic formulation manufacturers in India and overseas. The company has a diversified portfolio of 150+ active pharmaceutical ingredients which are used in major therapeutic areas such as gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. Our API manufacturing facilities adhere to cGMP (ICH Q7) and are inspected on a regular basis by international regulatory bodies. We have eight commercially inspected USFDA production plants, six in India and one each in Mexico and the United Kingdom.
Dr. Reddy's API business operates in a number of global markets, including the United States of America, Latin America, Europe, India, Russia, and other CIS nations.
Dr. Reddy's is among the top sustainable pharmaceutical companies globally. We are listed in the sustainability yearbook of S&P 2022 for the second year in a row and the Bloomberg Gender-Equality Index (GEI) for the fifth consecutive year. In addition, we were ranked ninth in the Dow Jones Sustainability Index (DJSI) 2021 among the most sustainable pharmaceutical companies in the world. In our sustainability journey, these accolades are humbling and demonstrate that we're on the right track. These awards recognize our consistent performance in the environment, social, and governance (ESG) framework. Sustainability and ESG are becoming increasingly important topics for all stakeholders, so we will strive to maintain visibility in these areas.
07/10/2021
The winner of the Best Indian Company in the US - Manufacturing Sector for the year 2021
03/11/2020
Dr. Reddy’s Laboratories wins “API Supplier of the Year” award at the Global Generics & Biosimilars Awards 2020
No information in this catalog - including any reference to any product or service - constitutes an offer for sale, or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. Products protected under valid patents in India are not available for commercial use but would be available for Section 107A purposes.